Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets for the year ending December 31, 2023: USD 590.47 M

Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets is USD 590.47 M for the year ending December 31, 2023, a 13.26% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 521.35 M, a 38.92% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 375.28 M, a 185.89% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 131.27 M, a 68.51% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 77.90 M, a 75.96% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years